You are here

Drug Forecast

Combating Non-nucleoside Reverse Transcriptase Inhibitor Resistance with a Focus On Etravirine (Intelence) for HIV-1 Infection

Nathaniel Eraikhuemen, PharmD, Angela M. Thornton, PharmD, Evans Branch III, PharmD, Sandrine T. Huynh, PharmD, and Candace Farley, PharmD
PDF version: 
The authors review etravirine (Intelence), a second-generation non-nucleoside reverse transcriptase inhibitor, for HIV-1 infection.